1. Home
  2. PZG vs ADVM Comparison

PZG vs ADVM Comparison

Compare PZG & ADVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Paramount Gold Nevada Corp.

PZG

Paramount Gold Nevada Corp.

HOLD

Current Price

$1.12

Market Cap

94.8M

ML Signal

HOLD

Logo Adverum Biotechnologies Inc.

ADVM

Adverum Biotechnologies Inc.

HOLD

Current Price

$4.19

Market Cap

94.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PZG
ADVM
Founded
1992
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
94.8M
94.6M
IPO Year
1999
2014

Fundamental Metrics

Financial Performance
Metric
PZG
ADVM
Price
$1.12
$4.19
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$11.60
AVG Volume (30 Days)
687.6K
432.2K
Earning Date
11-14-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$1,191.10
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.31
$1.78
52 Week High
$1.41
$6.45

Technical Indicators

Market Signals
Indicator
PZG
ADVM
Relative Strength Index (RSI) 44.69 46.81
Support Level $1.18 $4.07
Resistance Level $1.26 $4.23
Average True Range (ATR) 0.08 0.08
MACD -0.01 -0.00
Stochastic Oscillator 24.00 54.35

Price Performance

Historical Comparison
PZG
ADVM

About PZG Paramount Gold Nevada Corp.

Paramount Gold Nevada Corp is an exploration-stage mining company. Together with its subsidiaries, the company is engaged in the business of acquiring, exploring, and developing precious metal projects in the United States. Also, it explores for gold and silver. The company enhances the value of projects by implementing exploration and engineering programs that are likely to expand and upgrade known mineralized material to reserves. Its projects include sleeper gold, grassy mountain gold, frost project, other non-material, and others.

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

Share on Social Networks: